Tuesday, 02 January 2024 12:17 GMT

Automated Pharmacy Compounding Systems Market Growing Toward USD 5.27 Billion In 2035


(MENAFN- GlobeNewsWire - Nasdaq) The global automated pharmacy compounding systems market size is valued at USD 2.95 billion in 2025 and is predicted to hit around USD 5.27 billion by 2035, rising at a 5.98% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.

Ottawa, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The global automated pharmacy compounding systems market size



How Did North America Dominate the Automated Pharmacy Compounding Systems Market in 2024?

North America held a major share of 40% of the market in 2024. The North American market for automated pharmacy compounding systems is experiencing robust growth, this growth is driven by factors like the demand for accurate, customised medications, increased adoption of robotics in pharmacies

What Made the Asia Pacific Significantly Grow in The Automated Pharmacy Compounding Systems Market In 2024?

Asia Pacific is expected to grow at a 9.0% CAGR during the forecast period. The automated pharmacy compounding systems market in the Asia Pacific is experiencing rapid growth. This expansion is driven by the rising prevalence of chronic diseases, the increasing need to minimise medication errors, and the greater adoption of technology. China is a key market within the region, anticipated to register the highest CAGR, while countries like India, Japan, and Singapore also contribute significantly to this growth.

Get the latest insights on life science industry segmentation with our Annual Membership:

Segmental Insights

By product,

The robotic compounding systems segment led with a 55% share of the automated pharmacy compounding systems market in 2024. Robotic compounding systems dominate the advanced pharmacy automation landscape, driven by their ability to deliver high-precision sterile preparations with minimal human intervention. Their adoption is growing in large hospital pharmacies and compounding centres where high throughput, safety, and standardisation are critical.

The automated liquid compounding systems segment is expected to be the fastest-growing at an 8.5% CAGR in the studied years. Automated liquid compounding systems are gaining traction as pharmacies increasingly prioritise workflow efficiency and consistency in liquid medication preparation. They are especially beneficial for pediatric, oncology, and TPN formulations where accurate liquid dosing is essential. Their simpler operational model also makes them more accessible for mid-sized pharmacy settings.

By technology,

The robotics-based systems segment held 60% revenue share of the market in 2024. Robotic-based systems represent the most technologically advanced segment, offering end-to-end automation with robotic arms, barcode-guided verification, and closed-system sterility protection. These systems are preferred in high-volume hospital compounding units due to their unmatched precision, reproducibility, and ability to handle hazardous drugs safely. Growing emphasis on staff safety and increased complexity of personalised medication are driving strong adoption of fully robotic technologies.

The semi-automated systems segment is expected to grow rapidly at an 8.0% CAGR during 2025-2034. Semi-automated systems remain relevant for facilities seeking improved accuracy and reduced workload without the high investment required for full robotic solutions. These systems combine automated dispensing or mixing capabilities with human oversight, making them suitable for smaller hospitals and outpatient pharmacies. Their flexibility and lower capital cost support steady demand, especially in emerging healthcare markets transitioning from manual compounding.

By end user,

The hospitals segment was dominant with a 50% revenue share of the market in 2024. Hospitals account for the largest share of automated pharmacy compounding system usage due to their high daily compounding volumes and the need to maintain sterile, accurate, and regulation-compliant medication preparation. Increasing prevalence of chronic diseases, rising demand for IV therapy, and stringent regulatory standards are pushing hospitals toward advanced compounding automation. Large tertiary care and oncology hospitals are particularly strong adopters

The retail pharmacies segment is expected to grow at a rapid CAGR of 8.5% in the predicted timeframe. Retail pharmacies are gradually adopting automated compounding technologies as personalised medicine, speciality drug dispensing, and customised formulations gain prominence. While adoption is still lower compared to hospitals, retail chains and speciality pharmacies are investing in semi-automated and select robotic systems to increase service differentiation, reduce turnaround time, and ensure consistent quality. Growth in chronic therapy programs and home infusion services further supports demand from this segment.

Become a valued research partner with us -

Recent Developments

  • In July 2025, Merck, a major science and technology company, introduced the AAW Automated Assay Workstation, a solution led by Opentrons, to automate routine laboratory experiments and minimise hands-on time with ensured consistency in results.
  • In February 2025, South Korea-based Hanmi launched Countmate, a fully automated vial dispensing machine personalised to the unique preferences of the Canadian and US markets.
  • In December 2024, Germfree, an innovator in modular and mobile cleanroom infrastructure, equipment, and services, launched Smarthood (trademarked) for IV medication preparation.

Browse More Insights of Towards Healthcare:

The global non-sterile compounding pharmacy market

The global compound management market

The compounded topical drug market

The global compounding pharmacy market

The global compounding chemotherapy market

The global GCC compounding pharmacy market

The U.S. compounding pharmacy market

The global vials used in compounding pharmacy market

The U.S. 503B compounding pharmacies market

Automated Pharmacy Compounding Systems Market Key Players List

  • Capsa Healthcare
  • IMA Group
  • ARxIUM
  • Medimix Systems
  • Cerner Corporation
  • McKesson Corporation
  • Cardinal Health
  • Parata Systems
  • Baxter International
  • Yuyama Co., Ltd.

Segments Covered in The Report

By Product

  • Robotic Compounding Systems
  • Tablet & Capsule Dispensers
  • Injectable Compounding Robots
  • Automated Liquid Compounding Systems
  • IV Admixture Systems
  • Oral Liquid Compounding Systems
  • Accessories & Software
  • Barcode Scanners & Labeling Systems
  • Compounding Software

By Technology

  • Robotic-Based Systems
  • Semi-Automated Systems

By End User

  • Hospitals
  • Clinics
  • Retail Pharmacies
  • Compounding Pharmacies

By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

Immediate Delivery Available | Buy This Premium Research @

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard:

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research

You can place an order or ask any questions, please feel free to contact us at ...

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web:

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest


MENAFN05122025004107003653ID1110442646



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search